Does BREXPIPRAZOLE Cause Musculoskeletal stiffness? 98 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 98 reports of Musculoskeletal stiffness have been filed in association with BREXPIPRAZOLE (Rexulti). This represents 0.7% of all adverse event reports for BREXPIPRAZOLE.
98
Reports of Musculoskeletal stiffness with BREXPIPRAZOLE
0.7%
of all BREXPIPRAZOLE reports
4
Deaths
16
Hospitalizations
How Dangerous Is Musculoskeletal stiffness From BREXPIPRAZOLE?
Of the 98 reports, 4 (4.1%) resulted in death, 16 (16.3%) required hospitalization.
Is Musculoskeletal stiffness Listed in the Official Label?
Yes, Musculoskeletal stiffness is listed as a known adverse reaction in the official FDA drug label for BREXPIPRAZOLE.
What Other Side Effects Does BREXPIPRAZOLE Cause?
Weight increased (1,589)
Product use in unapproved indication (1,188)
Off label use (937)
Akathisia (807)
Drug ineffective (730)
Tardive dyskinesia (558)
Tremor (552)
Anxiety (475)
Product use issue (434)
Suicidal ideation (427)
What Other Drugs Cause Musculoskeletal stiffness?
ADALIMUMAB (10,762)
METHOTREXATE (9,903)
ETANERCEPT (9,744)
TOFACITINIB (7,354)
TOCILIZUMAB (6,346)
RITUXIMAB (6,058)
LEFLUNOMIDE (6,031)
ABATACEPT (5,926)
SECUKINUMAB (5,655)
HYDROXYCHLOROQUINE (5,271)
Which BREXPIPRAZOLE Alternatives Have Lower Musculoskeletal stiffness Risk?
BREXPIPRAZOLE vs BREXUCABTAGENE AUTOLEUCEL
BREXPIPRAZOLE vs BRIGATINIB
BREXPIPRAZOLE vs BRILINTA
BREXPIPRAZOLE vs BRILIQUE
BREXPIPRAZOLE vs BRIMONIDINE